twenty-nine boys with attention deficit disorder/hyperactivity were randomly assigned to receive desipramine ( dmi ; n = 17 ) or placebo ( n = 12 ) for 14 days in a noncrossover , double-blind study .
C1263846
with attention deficit disorder/hyperactivity
C0011685
desipramine